Daniel Paproth Rise and Shine: What you need to know before the ASX opens November 8, 2019 On Stockhead today, Tim Goyder and the secret behind his magical small cap ‘four-peat’, there's a 'seismic shift' taking place in… Cann Group starts importing as it continues to wait for Australian regulators November 7, 2019 Pot stock Cann Group (ASX:CAN) has "moved into the commercialisation phase" -- but it's with imported products, as it continues to wait… Tech: Farsighted people might one day be able to use smartphones without glasses November 7, 2019 People who are farsighted -- the inability to see close-up objects clearly -- might one day be able to use… Rise and Shine: What you need to know before the ASX opens November 7, 2019 On Stockhead today, Ora Gold's Phil Crabb chats to Bevis Yeo about rising metals demand, royalties and the environment, October's Top 50… Escrow Watch: 300 million shares are marching onto the ASX this fortnight November 6, 2019 Want to know when shares are coming out of escrow? We’ve been keeping tabs, so you don’t have to. Every… The ASX’s newest pot stock wants to deliver shareholder returns now, not later November 6, 2019 Rodney Cocks, the CEO of the company to be the ASX's newest pot stock, says he wants to deliver shareholder… Lunchtime ASX small cap wrap: Who bought more than they bargained for today? November 6, 2019 A New Zealand man is trying to sell 1,000 chickens that he accidentally bought in an auction for $1.50. Stuff reports… Food & Ag: It looks like the sun is finally starting to shine for Murray River Organics November 6, 2019 Long-suffering shareholders in Murray River Organics (ASX:MRG), which has experienced near-constant upheaval amid consistent bad news in its three years… Rise and Shine: What you need to know before the ASX opens November 4, 2019 On Stockhead today, the ASX-listed biotechs that are the closest to commercialising a drug, October's top 10 oil & gas… These are the 22 small cap biotechs closest to bringing a drug to market November 3, 2019 There are no shortage of small cap health and biotech companies listed on the ASX -- around 140 or so… Health: After seven months OncoSil has picked itself up off the canvas November 1, 2019 Seven months after it received a towering blow from the British Standards Institute (BSI) denying regulatory approval for its pancreatic… Check-up: Novita cracked some codes in the US and sextupled its share price November 1, 2019 Here’s our fortnightly wrap of the major small cap health stock winners and losers. One small cap ASX healthcare company… Lunchtime ASX small cap wrap: Who’s smelling cannabis today? October 31, 2019 One undisclosed Sydney man is sick of the smell of it. Having suffered sinus problems and headaches for nearly 20… Health: EMVision has built its portable brain scanner, trial to begin imminently October 31, 2019 Brain-scanning medtech EMVision (ASX:EMV) has finished building its portable brain scanner and is set to trial the tech on humans before the… With M&A heating up in Aus cannabis, is it international land grab time? October 17, 2019 For a while there, it seemed like the Australian cannabis sector had stalled. Not only were many cannabis companies in… Investors flocking to Melbourne for southern hemisphere’s biggest biotech investment conference October 17, 2019 Investors, brokers, high-ranking delegates, big pharma and Aussie small caps will all be sharing a room at the upcoming AusBiotech… Health: the hits keep coming for Avecho Biotechnology October 17, 2019 Avecho Biotechnology (ASX:AVE), the company formerly known as Phosphagenics, announced that its Japanese partner is pulling support after three years… Next» « Previous